Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Hematopoietic stem cell transplantation in qatar: One-year anniversary.

Bakr M, Al-Hijji I, Menasria N, Merenkov Z, Al-Azzawi S, Taha R, Gulied A, Gillespie CA, Dermime S, Liakopoulou E, Knuth A.

Hematol Oncol Stem Cell Ther. 2017 Dec;10(4):299-302. doi: 10.1016/j.hemonc.2017.06.002. Epub 2017 Jun 29.

2.

Precision Medicine and Non-Colorectal Cancer Liver Metastases: Fiction or Reality?

Liakopoulou E, Knuth A.

Viszeralmedizin. 2015 Dec;31(6):434-9. doi: 10.1159/000442485. Epub 2015 Dec 4. Review.

3.

Can we deconstruct cancer, one patient at a time?

Blau CA, Liakopoulou E.

Trends Genet. 2013 Jan;29(1):6-10. doi: 10.1016/j.tig.2012.09.004. Epub 2012 Oct 23.

4.

The granulocytes in neutropenia 1 (GIN 1) study: a safety study of granulocytes collected from whole blood and stored in additive solution and plasma.

Massey E, Harding K, Kahan BC, Llewelyn C, Wynn R, Moppett J, Robinson SP, Green A, Lucas G, Sadani D, Liakopoulou E, Bolton-Maggs P, Marks DI, Stanworth S.

Transfus Med. 2012 Aug;22(4):277-84. doi: 10.1111/j.1365-3148.2012.01152.x. Epub 2012 May 16.

PMID:
22591484
5.

The Meaning of Food (MOF): the development of a new measurement tool.

Ogden J, Liakopoulou E, Antilliou G, Gough G.

Eur Eat Disord Rev. 2012 Sep;20(5):423-6. doi: 10.1002/erv.1141. Epub 2011 Jul 25.

PMID:
21793109
6.

Factors influencing the outcome of a second autologous stem cell transplant (ASCT) in relapsed multiple myeloma: a study from the British Society of Blood and Marrow Transplantation Registry.

Cook G, Liakopoulou E, Pearce R, Cavet J, Morgan GJ, Kirkland K, Lee J, Davies FE, Hall R, Rahemtulla A, Russell N, Marks DI; British Society of Blood & Marrow Transplantation Clinical Trials Committee.

Biol Blood Marrow Transplant. 2011 Nov;17(11):1638-45. doi: 10.1016/j.bbmt.2011.04.005. Epub 2011 Apr 23.

7.

Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease.

Shaw BE, Apperley JF, Russell NH, Craddock C, Liakopoulou E, Potter MN, Wynn R, Gibson B, Pearce RM, Kirkland K, Lee J, Madrigal JA, Cook G, Byrne JL.

Br J Haematol. 2011 Apr;153(2):244-52. doi: 10.1111/j.1365-2141.2011.08615.x. Epub 2011 Mar 8.

PMID:
21382020
8.

Donor cell leukemia following unrelated donor bone marrow transplantation for primary granulocytic sarcoma of the small intestine.

Wiseman DH, Das M, Poulton K, Liakopoulou E.

Am J Hematol. 2011 Mar;86(3):315-8. doi: 10.1002/ajh.21938. Epub 2011 Feb 15. No abstract available.

9.

Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study.

Cordonnier C, Rovira M, Maertens J, Olavarria E, Faucher C, Bilger K, Pigneux A, Cornely OA, Ullmann AJ, Bofarull RM, de la Cámara R, Weisser M, Liakopoulou E, Abecasis M, Heussel CP, Pineau M, Ljungman P, Einsele H; Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants (VOSIFI) study group; Infectious Diseases Working Party, European Group for Blood and Marrow Transplantation.

Haematologica. 2010 Oct;95(10):1762-8. doi: 10.3324/haematol.2009.020073. Epub 2010 Jul 15.

10.

Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia.

Craddock C, Nagra S, Peniket A, Brookes C, Buckley L, Nikolousis E, Duncan N, Tauro S, Yin J, Liakopoulou E, Kottaridis P, Snowden J, Milligan D, Cook G, Tholouli E, Littlewood T, Peggs K, Vyas P, Clark F, Cook M, Mackinnon S, Russell N.

Haematologica. 2010 Jun;95(6):989-95. doi: 10.3324/haematol.2009.013920. Epub 2009 Nov 30.

11.

Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission.

Patel B, Kirkland KE, Szydlo R, Pearce RM, Clark RE, Craddock C, Liakopoulou E, Fielding AK, Mackinnon S, Olavarria E, Potter MN, Russell NH, Shaw BE, Cook G, Goldstone AH, Marks DI.

Haematologica. 2009 Oct;94(10):1399-406. doi: 10.3324/haematol.2009.008649. Epub 2009 Jul 31.

12.

Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome.

Robinson SP, Sureda A, Canals C, Russell N, Caballero D, Bacigalupo A, Iriondo A, Cook G, Pettitt A, Socie G, Bonifazi F, Bosi A, Michallet M, Liakopoulou E, Maertens J, Passweg J, Clarke F, Martino R, Schmitz N; Lymphoma Working Party of the EBMT.

Haematologica. 2009 Feb;94(2):230-8. doi: 10.3324/haematol.13441. Epub 2008 Dec 9.

13.

Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia.

Tholouli E, Liakopoulou E, Greenfield HM, Shaw BE, Tauro S, Byrne JL, Dennis M, Burthem J, Lucas GS, Craddock C, Russell NH, Liu Yin JA.

Br J Haematol. 2008 Jun;142(2):318-20. doi: 10.1111/j.1365-2141.2008.07184.x. Epub 2008 May 19. No abstract available.

PMID:
18492100
14.

Successful treatment of refractory joint contractures caused by sclerodermatous graft versus host disease.

Kim JB, Liakopoulou E, Watson JS.

J Plast Reconstr Aesthet Surg. 2008 Oct;61(10):1235-8. Epub 2007 May 23.

PMID:
17509955
15.

HLA-DR15, reduced relapse rate and improved survival after HLA identical sibling hemopoietic stem cell transplantation.

Davidson JA, Tate DG, Poulton KV, Lucas GS, Yin JL, Liakopoulou EF, Wynn R.

Biol Blood Marrow Transplant. 2007 Apr;13(4):493-4. Epub 2007 Feb 8. No abstract available.

16.

Rotavirus as a significant cause of prolonged diarrhoeal illness and morbidity following allogeneic bone marrow transplantation.

Liakopoulou E, Mutton K, Carrington D, Robinson S, Steward CG, Goulden NJ, Cornish JM, Marks DI.

Bone Marrow Transplant. 2005 Oct;36(8):691-4.

PMID:
16113671
17.

Stage-specific alterations in serum levels of G-CSF in chronic myeloid leukaemia.

Jørgensen HG, Allan EK, Jiang X, Liakopoulou E, Richmond L, Eaves CJ, Eaves AC, Holyoake TL.

Leukemia. 2003 Jul;17(7):1430-2. No abstract available.

PMID:
12835742
18.
19.

A decision support software package for medical treatment of I.C.U. patients.

Sphiris N, Nanas S, Paraskevopoulou H, Lymberis A, Kyprianou T, Liakopoulou E, Roussos C.

Stud Health Technol Inform. 1997;43 Pt B:911-4.

PMID:
10179801
20.

Stimulation of fetal hemoglobin production by short chain fatty acids.

Liakopoulou E, Blau CA, Li Q, Josephson B, Wolf JA, Fournarakis B, Raisys V, Dover G, Papayannopoulou T, Stamatoyannopoulos G.

Blood. 1995 Oct 15;86(8):3227-35.

PMID:
7579419
21.

Fetal hemoglobin induction by acetate, a product of butyrate catabolism.

Stamatoyannopoulos G, Blau CA, Nakamoto B, Josephson B, Li Q, Liakopoulou E, Pace B, Papayannopoulou T, Brusilow SW, Dover G.

Blood. 1994 Nov 1;84(9):3198-204.

PMID:
7524768

Supplemental Content

Loading ...
Support Center